Children with COVID-19 behaving milder may challenge the public policies: a systematic review and meta-analysis

Chan Liu1, Yu He1, Lian Liu1

  • 1Department of Neonatology, Children's Hospital of Chongqing Medical University; National Clinical Research Center for Child Health and Disorders; Ministry of Education Key Laboratory of Child Development and Disorders, China International Science and Technology Cooperation base of Child Development and Critical Disorders; Chongqing Key Laboratory of Pediatrics, Chongqing, 400014, People's Republic of China.

BMC Pediatrics
|September 3, 2020
PubMed

Insights

Children infected with the emerging virus (COVID-19) rarely experience severe illness or death, but they can transmit the virus. Public health policies must balance transmission control with the well-being of children, considering prolonged school closures.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • The global spread of a novel virus has led to an increase in reported pediatric cases.
  • Understanding the characteristics and impact of the virus on children is crucial for effective public health strategies.

Purpose of the Study:

  • To analyze the clinical characteristics and outcomes of pediatric patients diagnosed with Coronavirus Disease 2019 (COVID-19).
  • To assess the impact of public health interventions, such as school closures, on children during the pandemic.

Main Methods:

  • A single-arm meta-analysis of 29 studies involving 4300 pediatric patients diagnosed with COVID-19.
  • Data were collected from December 2019 to May 2020, with quality appraisal and bias analysis.
  • Subgroup analysis by geographic region and review of educational disruption policies were conducted.

Main Results:

  • The mean age of infected children was 7.04 years.
  • 18.9% of pediatric cases were asymptomatic, and 37.4% had no radiographic abnormalities.
  • Severe outcomes were rare, with 0.1% ICU admission and four reported deaths among the analyzed cases. Nationwide school closures affected over 70% of students globally.

Conclusions:

  • Children are susceptible to SARS-CoV-2 but typically present with mild illness, with critical cases and deaths being infrequent.
  • The potential for children to act as asymptomatic spreaders presents a public health dilemma.
  • Strict management strategies, including prolonged school closures, pose risks to children's well-being, challenging current public policies.
Abstract

Related Concept Videos

Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
1.1K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
108
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
131
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
147
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
172